Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
88.1M
-
Number of holders
-
116
-
Total 13F shares, excl. options
-
46M
-
Shares change
-
+1.25M
-
Total reported value, excl. options
-
$835M
-
Value change
-
+$24.1M
-
Put/Call ratio
-
0
-
Number of buys
-
72
-
Number of sells
-
-36
-
Price
-
$18.17
Significant Holders of IDEAYA Biosciences, Inc. - Common Stock (IDYA) as of Q4 2022
131 filings reported holding IDYA - IDEAYA Biosciences, Inc. - Common Stock as of Q4 2022.
IDEAYA Biosciences, Inc. - Common Stock (IDYA) has 116 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 46M shares
of 88.1M outstanding shares and own 52.18% of the company stock.
Largest 10 shareholders include Logos Global Management LP (3.9M shares), Avidity Partners Management LP (3.82M shares), BlackRock Inc. (3.54M shares), FEDERATED HERMES, INC. (2.86M shares), Canaan Partners X LLC (2.66M shares), STATE STREET CORP (2.32M shares), VANGUARD GROUP INC (2.29M shares), BVF INC/IL (2.21M shares), Boxer Capital, LLC (2.2M shares), and ADAGE CAPITAL PARTNERS GP, L.L.C. (2.2M shares).
This table shows the top 116 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.